Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4

Blood Cells, Molecules, and Diseases

Volumn 28, Issue 2, 2002, Pages 221-233

  Fuchs, Ota ^a   Simakova, Olga ^a   Klener, Pavel ^b   Cmejlova, Jana ^a   Zivny, Jan ^b   Zavadil, Jiri ^c   Stopka, Tomas ^a,c  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CD34 ANTIGEN; MESSENGER RNA; SMAD PROTEIN; SMAD5 PROTEIN; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; BONE MORPHOGENETIC PROTEIN; DNA BINDING PROTEIN; GLYCOPHORIN; PHOSPHOPROTEIN; SMAD5 PROTEIN, HUMAN; SMAD5 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROLEUKEMIA CELL; GRANULOCYTE PRECURSOR; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MACROPHAGE; MOUSE; MYELODYSPLASIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; ANIMAL; BIOSYNTHESIS; CASE CONTROL STUDY; CELL CULTURE; CYTOLOGY; DNA MICROARRAY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PATHOLOGY; PHYSIOLOGY;

MURINAE;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ANTIGENS, CD34; BONE MORPHOGENETIC PROTEINS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; ERYTHROID PROGENITOR CELLS; GENE EXPRESSION REGULATION; GLYCOPHORIN; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID; MICE; MYELODYSPLASTIC SYNDROMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOPROTEINS; SIGNAL TRANSDUCTION; SMAD5 PROTEIN; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0036304178     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2002.0487     Document Type: Article

References (44)

1. The 5q-anomaly
2. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7
3. Cytogenetic study of 130 patients with acute nonlymphocytic leukemia
4. Mad-related genes in the human
5. Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor
6. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60
7. Signaling inputs converge on nuclear effectors in TGF-beta signaling
8. Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH
9. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q-chromosome
10. Physical mapping of the minimal region of loss in 5q- chromosome
11. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map
12. A radiation hybrid breakpoint map of the acute myeloid leukemia (AML) and limb-girdle muscular dystrophy 1A (LGMD1A) regions of chromosome 5q31 localizing 122 expressed sequences
13. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31
14. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31
15. Deletions of PURA, at 5q31, and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia
16. Mutation and cancer: Statistical study of retinoblastoma
17. Signal transduction by bone morphogenetic proteins
18. The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis
19. BMP-like signals are required after the midblastula transition for blood cell development
20. Smad5 induces ventral fates in Xenopus embryo
21. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse
22. Bone mor-phogenetic proteins regulate the developmental program of human hematopoietic stem cells
23. Bone morphogenetic protein 4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro
24. Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia
25. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis
26. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: Stimulation of erythroid differentiation by dimethyl sulfoxide
27. Erythroleu-kemic differentiation
28. An early haematopoietic defect in mice lacking the transcription factor GATA-2
29. Direct interaction of hematopoietic transcription factors PU.1 and GATA- 1: Functional antagonism in erythroid cells
30. The transforming growth factor beta family and induction of the vertebrate mesoderm: Bone morphogenetic proteins are ventral inducers
31. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development
32. Opposite effects of FGF and BMP-4 on embryonic blood formation: Roles of PV.1 and GATA-2
33. The BMP/BMPR/Smad pathway directs expression of the erythroid-specific EKLF and GATA1 transcription factors during embryoid body differentiation in serum-free media
34. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects
35. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5
36. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice
37. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice
38. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis
39. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis
40. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma
41. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
42. Analysis of the Smad5 gene in hematological malignancies
43. hSmad5 gene, a human hSmad family member: Its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors
44. An antisense transcript to SMAD5 expressed in fetal and tumor tissues